Patient-therapist INTERaction During RObotic GAIT Rehabilitation After Spinal Cord Injury
Patient-therapist INTERaction During RObotic GAIT Rehabilitation After Spinal Cord Injury: Clinical, Instrumental and Hyperscanning Study.
I.R.C.C.S. Fondazione Santa Lucia
30 participants
Jun 5, 2024
INTERVENTIONAL
Conditions
Summary
INTERROGAIT will disentangle the role of Physical Therapist - Patient (Pht-Pt) interaction in robotic assisted gait rehabilitation in spinal cord injury patients. The study is structured as a single blind randomized controlled trial with two arms, in which effects of different Pht-Pt interaction levels will be assessed on the ongoing robotic treatment with the Lokomat device. The main hypothesis is that when Pht-Pt interaction is maximized (experimental group), this will allow to better rehabilitation outcome with respect to a minimun level of Pht-Pt interaction (control group).
Eligibility
Inclusion Criteria5
- incomplete SCI lesion (ISNCSCI AIS level C or D);
- subacute or chronic iSCI;
- traumatic and non-traumatic aetiology;
- SCI at or above T12 level;
- absence of severe cognitive impairment such as to interfere with the protocol.
Exclusion Criteria2
- lack of the clinical requirements for using Lokomat;
- anything preventing EEG recording.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients will underwent 12 RAGT training sessions (3 times/week for 4 consecutive weeks, 45 min each including the time for wearing the harness and the exoskeleton) with the Lokomat device as add-on to conventional regimen (5 times/week, 80 min each). The Lokomat is a technologically advanced robot-assisted gait training device. Patients are supported in a harness above a treadmill while the robotic device assists the movements of their legs to provide physiological gait. As treatment progresses, weight bearing is increased and assistance from the robotic legs is reduced, requiring the patient to gradually assume greater responsibility for movements needed during walking.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06531304